Get started

Labor für Immunologische und Molekulare Krebsforschung

Homepage: limcr.at
Alternate names: SCRI-LIMCR GmbH, Salzburg Cancer Research Institute Laboratory for Immunological and Molecular Cancer Research
Parent institution: Salzburger Landeskliniken
ROR: 037w8vx49
OpenAlex ID: I4405255624
Remdesivir for the Treatment of Hospitalised Patients with COVID-19 (DisCoVeRy): A Randomised, Controlled, Open-Label Trial
2021 · Florence Ader, Maude Bouscambert-Duchamp, et al. · The Lancet Infectious Diseases · 347
PDF
T cells in multiple myeloma display features of exhaustion and senescence at the tumor site
2016 · Claudia Zelle-Rieser, Shanmugapriya Thangavadivel, et al. · Journal of Hematology & Oncology · 331
PDF
p53 Efficiently Suppresses Tumor Development in the Complete Absence of Its Cell-Cycle Inhibitory and Proapoptotic Effectors p21, Puma, and Noxa
2013 · Liz J. Valente, Daniel H.D. Gray, et al. · Cell Reports · 298
PDF
HER2 Directed Antibody-Drug-Conjugates beyond T-DM1 in Breast Cancer
2019 · Gabriel Rinnerthaler, Simon Peter Gampenrieder, et al. · International Journal of Molecular Sciences · 225
PDF
T cell exhaustion: from pathophysiological basics to tumor immunotherapy
2017 · Kemal Catakovic, Eckhard Klieser, et al. · Cell Communication and Signaling · 208
PDF
Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera
2015 · Heinz Gisslinger, Oleh Zagrijtschuk, et al. · Blood · 204
CAR T-Cell Therapy in Hematological Malignancies
2021 · Theresa Haslauer, Richard Greil, et al. · International Journal of Molecular Sciences · 192
PDF
Imprecision and DNA Break Repair Biased towards Incompatible End Joining in Leukemia
2017 · Franz Josef Gassner, Maria Schubert, et al. · Molecular Cancer Research · 156
Bim and Bmf in tissue homeostasis and malignant disease
2008 · J D Piñon, V Labi, et al. · Oncogene · 150
Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry
2021 · Simon Peter Gampenrieder, Gabriel Rinnerthaler, et al. · Breast Cancer Research · 146
PDF
Molecular and cellular mechanisms of CLL: novel therapeutic approaches
2009 · Lisa Pleyer, Alexander Egle, et al. · Nature Reviews Clinical Oncology · 141
PDGFR blockade is a rational and effective therapy for NPM-ALK–driven lymphomas
2012 · Daniela Laimer, Helmut Dolznig, et al. · Nature Medicine · 129
PDF
AID/APOBEC deaminases and cancer
2015 · Stefan Rebhandl, Michael Huemer, et al. · Oncoscience · 128
PDF
Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis
2020 · Hannes Neuwirt, Jan Bouchal, et al. · Cell Communication and Signaling · 110
PDF
The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients
2010 · S. Perkhofer, C. Lass-Flörl, et al. · International Journal of Antimicrobial Agents · 104
Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial
2020 · for the ACT-2 study investigators, Gerald G. Wulf, et al. · Leukemia · 99
PDF
Adhesion molecules and chemokines: the navigation system for circulating tumor (stem) cells to metastasize in an organ-specific manner
2007 · Thomas Dittmar, Christoph Heyder, et al. · Clinical & Experimental Metastasis · 99
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia
2018 · Erika Tissino, Dania Benedetti, et al. · The Journal of Experimental Medicine · 97
PDF
miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites
2016 · Gabriel Rinnerthaler, Hubert Hackl, et al. · International Journal of Molecular Sciences · 92
PDF
Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations
2021 · William G. Wierda, Andrew Rawstron, et al. · Leukemia · 91
PDF
Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR)
2019 · Simon Peter Gampenrieder, Andreas Peer, et al. · Breast Cancer Research · 91
PDF
Circulating B-Cell Chronic Lymphocytic Leukemia Cells Display Impaired Migration to Lymph Nodes and Bone Marrow
2009 · Tanja Nicole Hartmann, Valentin Grabovsky, et al. · Cancer Research · 88
TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia
2017 · Kemal Catakovic, Franz Josef Gassner, et al. · OncoImmunology · 87
PDF
Transcriptomic Profiling Identifies CD8+ T Cells in the Brain of Aged and Alzheimer’s Disease Transgenic Mice as Tissue-Resident Memory T Cells
2022 · Barbara Altendorfer, Michael Stefan Unger, et al. · The Journal of Immunology · 77
Next Generation Sequencing in AML—On the Way to Becoming a New Standard for Treatment Initiation and/or Modulation?
2019 · Michael Leisch, Bettina Jansko, et al. · Cancers · 76
Works count: 409
Citation count: 27,970
Year
Topic
Type